This compound is an amino-substituted quinazoline derivative used as a pharmaceutical intermediate in the manufacturing of afatinib-related impurities. It is characterized by the presence of aromatic rings, amine groups, and halogen atoms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-N4-(3,4-Dichlorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
pharmaceutical intermediate
7-fluoro-2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one
pharmaceutical intermediate
N-Boc-L-pyroglutamic acid ethyl ester
pharmaceutical intermediate
Ethyl Boc-D-pyroglutamate
pharmaceutical intermediate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic acid 1-methyl ester
pharmaceutical intermediate
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine
pharmaceutical intermediate
Erlotinib hydrochloride
pharmaceutical raw material
6-amino-4-(3-chloro-4-fluoroanilino)quinazolin-7-ol
YEFNIUDZICAGOU-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)N)O)Cl)F
Sourcing 6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.